SCHEMBL332607

SCHEMBL332607

O=C1OCc2c1cccc2[N+](=O)[O-]

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.53
S100A4 P26447 2/20 0.50
KCNJ1 P48048 1/20 0.49
KCNH2 Q12809 1/20 0.49
MAPT P10636 5/20 0.49
RECQL P46063 1/20 0.49
KMT2A Q03164 1/20 0.49
MCL1 Q07820 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49
ALDH1A1 P00352 5/20 0.48
LMNA P02545 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
MITF O75030 1/20 0.48
HTT P42858 1/20 0.48
PTPRC P08575 1/20 0.46
TDP1 Q9NUW8 3/20 0.44
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13046531 0.83 S100A4 (0.47) POLBS100A4KCNJ1KCNH2MAPT
SCHEMBL7248426 0.79 MAPT (0.50) POLBS100A4MAPTRECQLKMT2A
SCHEMBL27539899 0.79 POLB (0.48) POLBS100A4KCNJ1KCNH2MAPT
SCHEMBL7248428 0.78 S100A4 (0.46) POLBS100A4MAPTRECQLKMT2A
SCHEMBL6554331 0.78 MAPT (0.40) POLBS100A4KCNJ1KCNH2MAPT
SCHEMBL16701465 0.76 MAPT (0.50) POLBS100A4MAPTRECQLKMT2A
SCHEMBL2049186 0.75 PGR (0.41) POLBKCNJ1KCNH2MAPTKMT2A
SCHEMBL2041366 0.75 POLB (0.39) POLBS100A4MAPTRECQLKMT2A
SCHEMBL29947934 0.75 PGR (0.41) POLBKCNJ1KCNH2MAPTKMT2A
SCHEMBL166701 0.74 MAPT (0.56) S100A4MAPTRECQLKMT2AMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114076801-B Detection method of related substances in lenalidomide 上海博志研新药物研究有限公司 2024-04-02 CN claimed
CN-114076801-A Method for detecting related substances in lenalidomide 上海博志研新药物技术有限公司 2022-02-22 CN claimed
CN-1319944-C Prepn process of N-methyl-4-(dimethyl phenoxy) phthalimide SHANGHAI CITY INST OF SYNTHETI (CN) 2007-06-06 CN claimed
CN-1706830-A Prepn process of N-methyl-4-(dimethyl phenoxy) phthalimide SHANGHAI CITY INST OF SYNTHETI (CN) 2005-12-14 CN claimed
CN-114076801-B Detection method of related substances in lenalidomide 上海博志研新药物研究有限公司 2024-04-02 CN disclosed
WO-2022238500-A1 RADIOSYNTHESIS OF [18F] TALAZOPARIB EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET (DE) 2022-11-17 WO disclosed
EP-4088745-A1 COMPOUND FOR THE DIAGNOSIS OF CANCER Eberhard Karls Universität Tübingen Medizinische Fakultät (DE) 2022-11-16 EP disclosed
EP-4089093-A1 RADIOSYNTHESIS OF [18F] TALAZOPARIB Eberhard Karls Universität Tübingen Medizinische Fakultät (DE) 2022-11-16 EP disclosed
US-11364241-B2 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) MEDIVATION TECHNOLOGIES LLC (US) 2022-06-21 US disclosed
CN-114076801-A Method for detecting related substances in lenalidomide 上海博志研新药物技术有限公司 2022-02-22 CN disclosed
US-20210069191-A1 DIHYDROPYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) MEDIVATION TECHNOLOGIES LLC 2021-03-11 US disclosed
US-10780088-B2 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) MEDIVATION TECHNOLOGIES LLC (US) 2020-09-22 US disclosed
US-20050171109-A1 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2005-08-04 US disclosed
US-20050131226-A1 Rearranged pentanols, a process for their production and their use as anti-inflammatory agents SCHERING AG (DE) 2005-06-16 US disclosed
WO-2005035518-A1 REARRANGED PENTANOLS, A METHOD FOR THE PRODUCTION THEREOF, AND THEIR USE AS ANTIPHLOGISTICS SCHERING AKTIENGESELLSCHAFT (DE) 2005-04-21 WO disclosed
WO-2005034939-A1 1-AMINO-2-OXY-SUBSTITUTED TETRAHYDRONAPHTALENE DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF, AND THEIR USE AS ANTIPHLOGISTICS SCHERING AKTIENGESELLSCHAFT (DE) 2005-04-21 WO disclosed
US-20030073850-A1 4-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use ABBOTT LABORATORIES 2003-04-17 US disclosed
US-4687508-A Herbicidal benzenesulfonamides E. I. DU PONT DE NEMOURS AND COMPANY (US) 1987-08-18 US disclosed
US-4578108-A Herbicidal benzenesulfonamides E. I. DU PONT DE NEMOURS AND COMPANY (US) 1986-03-25 US disclosed
US-4521241-A PLANT GROWTH REGULATORS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1985-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10780088-B2 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) PARP1, PARP2, PARP11 POLB 19/4885S100A4 4760/4885KCNJ1 3516/4885
US-20030073850-A1 4-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use ADRA1D, ADRB1, ADRA1A POLB 4410/4885S100A4 1602/4885KCNJ1 555/4885
US-11364241-B2 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) PARP1, PARP2, PARP11 POLB 19/4885S100A4 4760/4885KCNJ1 3516/4885
US-20050171109-A1 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents TNF, DHPS, PTGES POLB 2124/4885S100A4 988/4885KCNJ1 3846/4885
US-20050131226-A1 Rearranged pentanols, a process for their production and their use as anti-inflammatory agents TNF, PTGES, PTGES2 POLB 1150/4885S100A4 1185/4885KCNJ1 4638/4885
US-20210069191-A1 DIHYDROPYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) PARP1, PARP2, PARP11 POLB 19/4885S100A4 4760/4885KCNJ1 3516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.